Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.52 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.52 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.52 |
| ▸ | FAAH | O00519 | 2/20 | 0.50 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7170235 | 1.00 | LPAR2 (0.52) | LPAR2LPAR3LPAR1FAAHTRPV1 | |
| Oleyl Alcohol SCHEMBL7625014 | 0.91 | LPAR2 (0.49) | LPAR2LPAR3LPAR1TRPV1 | |
| Oleyl Alcohol SCHEMBL7625020 | 0.91 | LPAR2 (0.49) | LPAR2LPAR3LPAR1TRPV1 | |
| SCHEMBL77168 | 0.86 | THRB (0.47) | LPAR2LPAR3LPAR1 | |
| SCHEMBL11592491 | 0.86 | THRB (0.47) | LPAR2LPAR3LPAR1 | |
| SCHEMBL2397962 | 0.86 | THRB (0.47) | LPAR2LPAR3LPAR1 | |
| SCHEMBL7172026 | 0.86 | THRB (0.47) | LPAR2LPAR3LPAR1 | |
| SCHEMBL9119727 | 0.86 | THRB (0.47) | LPAR2LPAR3LPAR1 | |
| SCHEMBL11572901 | 0.86 | THRB (0.47) | LPAR2LPAR3LPAR1 | |
| SCHEMBL766409 | 0.86 | THRB (0.47) | LPAR2LPAR3LPAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10590151-B2 | Silanes and curable compositions comprising said silanes | HENKEL AG & CO. KGAA (DE) | 2020-03-17 | — | — | US | disclosed |
| US-20190202844-A1 | Silanes and Curable Compositions Comprising Said Silanes | HENKEL AG & CO. KGAA (DE) | 2019-07-04 | — | — | US | disclosed |
| EP-3293188-B1 | SILANES AND CURABLE COMPOSITIONS COMPRISING SAID SILANES | HENKEL AG & CO KGAA (DE) | 2019-04-10 | — | — | EP | disclosed |
| WO-2018050503-A1 | SILANES AND CURABLE COMPOSITIONS COMPRISING SAID SILANES | HENKEL AG & CO. KGAA (DE) | 2018-03-22 | — | — | WO | disclosed |
| EP-3293188-A1 | SILANES AND CURABLE COMPOSITIONS COMPRISING SAID SILANES | Henkel AG & Co. KGaA (DE) | 2018-03-14 | — | — | EP | disclosed |
| US-20030216504-A1 | Biomimetic silicone elastomers | XIOMATERIA LIMITED (IE) | 2003-11-20 | — | — | US | disclosed |
| EP-1244738-B1 | BIOMIMETIC SILICONE ELASTOMERS | XIOMATERIA LTD (GB) | 2003-06-11 | — | — | EP | disclosed |
| WO-2002090436-A2 | BIOACTIVE BIOMIMETIC ELASTOMERS | XIOMATERIA LIMITED (GB) | 2002-11-14 | — | — | WO | disclosed |
| EP-1244738-A1 | BIOMIMETIC SILICONE ELASTOMERS | Xiomateria Limited (GB) | 2002-10-02 | — | — | EP | disclosed |
| WO-2001034695-A1 | BIOMIMETIC SILICONE ELASTOMERS | XIOMATERIA LIMITED (GB) | 2001-05-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10590151-B2 | Silanes and curable compositions comprising said silanes | CLNS1A, RCC1, RIF1 | LPAR2 2802/4885LPAR3 3307/4885LPAR1 1860/4885 |
| US-20190202844-A1 | Silanes and Curable Compositions Comprising Said Silanes | CLNS1A, RCC1, RIF1 | LPAR2 2802/4885LPAR3 3307/4885LPAR1 1860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.